- Home
- HBIO vs TLSA Comparison
HBIO vs TLSA Comparison
Compare HBIO & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- TLSA
- Stock Information
- Founded
- HBIO 1901
- TLSA 2013
- Country
- HBIO United States
- TLSA United Kingdom
- Employees
- HBIO N/A
- TLSA N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- HBIO Industrials
- TLSA Health Care
- Exchange
- HBIO Nasdaq
- TLSA Nasdaq
- Market Cap
- HBIO 93.8M
- TLSA 87.8M
- IPO Year
- HBIO 2000
- TLSA 2000
- Fundamental
- Price
- HBIO $1.93
- TLSA $0.74
- Analyst Decision
- HBIO
- TLSA
- Analyst Count
- HBIO 0
- TLSA 0
- Target Price
- HBIO N/A
- TLSA N/A
- AVG Volume (30 Days)
- HBIO 248.4K
- TLSA 442.0K
- Earning Date
- HBIO 03-06-2025
- TLSA 01-28-2025
- Dividend Yield
- HBIO N/A
- TLSA N/A
- EPS Growth
- HBIO N/A
- TLSA N/A
- EPS
- HBIO N/A
- TLSA N/A
- Revenue
- HBIO $97,732,000.00
- TLSA N/A
- Revenue This Year
- HBIO N/A
- TLSA N/A
- Revenue Next Year
- HBIO $4.32
- TLSA N/A
- P/E Ratio
- HBIO N/A
- TLSA N/A
- Revenue Growth
- HBIO N/A
- TLSA N/A
- 52 Week Low
- HBIO $1.81
- TLSA $0.41
- 52 Week High
- HBIO $4.93
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- HBIO 40.61
- TLSA 44.91
- Support Level
- HBIO $1.81
- TLSA $0.68
- Resistance Level
- HBIO $2.07
- TLSA $0.80
- Average True Range (ATR)
- HBIO 0.13
- TLSA 0.08
- MACD
- HBIO -0.01
- TLSA 0.01
- Stochastic Oscillator
- HBIO 25.53
- TLSA 34.34
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.